The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.
You can find a full list of media coverage about MFICM on the News page
The first patient has taken part in a research study testing a new scanning method to improve the detection of ovarian cancer.
The Cambridge Festival cancer zone will take place on Saturday 22nd March 2025, 11:00 – 16:00 in the CAST building on the Biomedical Campus
An MRI-based imaging technique developed at the University of Cambridge predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
